Amneal Pharmaceuticals, Inc. (AMRX) Operating Lease, Payments USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Amneal Pharmaceuticals, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending December 31, 2019 was $5.15 M.
  • Amneal Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending December 31, 2019 was $20.1 M.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $16 M, a 1.12% decline from 2022.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $16.2 M, a 8.07% increase from 2021.
  • Amneal Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $15 M, a 20.1% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16 M -$181 K -1.12% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $16.2 M +$1.21 M +8.07% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $15 M -$3.77 M -20.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-03
2020 $18.8 M -$1.34 M -6.67% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $20.1 M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.